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ARTICLE
Genetic correlations of psychiatric traits with
body composition and glycemic traits are
sex- and age-dependent
Christopher Hübel 1,2,3*, Heĺeńa A. Gaspar 1,2, Jonathan R.I. Coleman 1,2, Ken B. Hanscombe4,
Kirstin Purves 1, Inga Prokopenko 5, Mariaelisa Graff6, Julius S. Ngwa7,8, Tsegaselassie Workalemahu9,
ADHD Working Group of the Psychiatric Genomics Consortium, Meta-Analyses of Glucose and Insulin-related
traits consortium (MAGIC), Autism Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder
Working Group of the Psychiatric Genomics Consortium, Eating Disorders Working Group of the Psychiatric
Genomics Consortium, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,
OCD & Tourette Syndrome Working Group of the Psychiatric Genomics Consortium, PTSD Working Group of
the Psychiatric Genomics Consortium, Schizophrenia Working Group of the Psychiatric Genomics Consortium,
Sex Differences Cross Disorder Working Group of the Psychiatric Genomics Consortium, Substance Use
Disorders Working Group of the Psychiatric Genomics Consortium, German Borderline Genomics Consortium,
International Headache Genetics Consortium, Paul F. O’Reilly 1, Cynthia M. Bulik 3,10,11 & Gerome Breen 1,2
Body composition is often altered in psychiatric disorders. Using genome-wide common genetic
variation data, we calculate sex-specific genetic correlations amongst body fat %, fat mass,
fat-free mass, physical activity, glycemic traits and 17 psychiatric traits (up to N= 217,568).
Two patterns emerge: (1) anorexia nervosa, schizophrenia, obsessive-compulsive disorder, and
education years are negatively genetically correlated with body fat % and fat-free mass, whereas
(2) attention-deficit/hyperactivity disorder (ADHD), alcohol dependence, insomnia, and heavy
smoking are positively correlated. Anorexia nervosa shows a stronger genetic correlation with
body fat % in females, whereas education years is more strongly correlated with fat mass in
males. Education years and ADHD show genetic overlap with childhood obesity. Mendelian
randomization identifies schizophrenia, anorexia nervosa, and higher education as causal for
decreased fat mass, with higher body fat % possibly being a causal risk factor for ADHD and
heavy smoking. These results suggest new possibilities for targeted preventive strategies.
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Psychiatric disorders are complex traits influenced bythousands of genetic variants that act in concert withenvironmental factors1,2. Genome-wide association studies
(GWASs) of psychiatric disorders have identified more than 300
independent genomic loci3,4, informed biological follow-up stu-
dies5 and may deliver promising targets for drug discovery and
repurposing6–8. Genome-wide summary statistics generated by
GWASs can be used in several different ways9, including esti-
mating single-nucleotide polymorphism-based heritability (h2SNP),
which is the phenotypic variance explained by common genomic
variants. Values of h2SNP range from 10 to 30% for psychiatric
disorders and typically capture around a third of the heritability
estimated by twin studies10. Additionally, genetic correlations can
be calculated using GWAS summary statistics via bivariate link-
age disequilibrium score regression (LDSC), which estimates the
genetic overlap (i.e. the shared genetic effects) between two
traits11,12. Such GWAS-based genetic correlation analyses have
shown substantial genetic overlap among psychiatric disorders13,
providing evidence for an underlying “p factor” representing
general liability for psychiatric illness14,15. For instance, genomic
structural equation modelling16 of GWAS summary statistics for
schizophrenia, bipolar disorder, major depressive disorder, post-
traumatic stress disorder and anxiety showed that they load onto
one shared latent factor with loading estimates between 0.29 and
0.8616. However, marked differences in the clinical presentation
of psychiatric disorders exist for psychotic experiences or dys-
functional reward systems, suggesting the existence of additional
disorder-specific genetic effects13,14,16.
Clinically, many psychiatric disorders are accompanied by
disturbances in appetite regulation, eating behaviour and altered
physical activity. These disturbances can alter body composition
and result in comorbid overweight or underweight17, most
prominently observed in eating disorders, such as binge-eating
disorder and anorexia nervosa18. Such severe weight dysregu-
lation typically reduces patients’ quality of life and is associated
with excess morbidity and mortality19. Body composition traits,
including body fat % (BF%) and fat-free mass (FFM), are
also complex, with substantial twin heritabilities of ~70%20,21.
Body mass index (BMI) is the most commonly studied body
composition phenotype and its associated genetic variants have
been found to be significantly overrepresented in genes and
genomic regions active in brain cell types22, suggesting it may be
a partially behavioural trait. Several studies have also shown
negative genetic correlations of BMI with anorexia nervosa
and schizophrenia12,23–25 and positive genetic correlations of
BMI with attention-deficit/hyperactivity disorder (ADHD) and
major depressive disorder26,27. These observations suggest
that an in-depth investigation of the shared genomics between
psychiatric and body composition traits is needed.
In addition, both extreme overweight and extreme underweight
show a clear sex difference: females are not only disproportionately
affected by anorexia nervosa (with ratios up to 15:1) but also by
obesity (≥30 kg/m2)28–30. Sex differences are not limited to
body composition: major depressive disorder31 and anxiety32 are
more common in females, whereas ADHD33 and autism spectrum
disorder34 occur more often in males. Sex differences in body
composition, psychiatry and their interplay are not fully under-
stood. Hormones and sex chromosomes have clearly been
demonstrated to play a role35, but are insufficient to fully explain
the sex differences36.
In this study, our primary aim is to identify pairs of traits with
shared genetic factors by calculating sex-specific genetic correla-
tions. To do so, we calculate sex-specific genetic correlations for
GWASs of 12 psychiatric disorders mostly supplied by the Psy-
chiatric Genomics Consortium (URLs) and five behavioural traits
with sex-specific GWASs of body composition traits derived from
a healthy and medication-free subsample of the UK Biobank
(URLs; Supplementary Tables 1, 2). These include BMI, BF%,
absolute fat mass (FM) and FFM, as well as body composition-
related traits, such as objectively measured physical activity from
the UK Biobank (URLs) and glycaemic traits from MAGIC
(URLs; Supplementary Data 1). We apply trait-specific illness and
medication filtering to obtain genomic variants that are associated
with body composition traits independent of the confounding
effects of somatic diseases, such as diabetes or endocrine illnesses
and addiction-related behaviours, including smoking and alcohol
consumption, as well as psychiatric disorders. Where possible,
putative causality is examined using generalized summary data-
based Mendelian randomization (GSMR)37 in females and males
separately. As a secondary aim, we use GWASs of BMI and FFM
from different stages of life, including childhood, adolescence,
young adulthood and late adulthood, to identify the develop-
mental stages in which the sharing of body composition genomic
factors with genetic liability for psychiatric disorders occurs.
Here, we show that the genomic overlap between body com-
position traits and psychiatric disorders is evident only in later
adulthood, whereas childhood and young adulthood GWASs of
BMI do not correlate significantly with psychiatric traits.
Accelerometer-measured physical activity shows genetic correla-
tions with obsessive compulsive disorder (OCD) and anorexia
nervosa, but with no other psychiatric disorder. In addition,
glycaemic traits show significant genetic correlations only with
anorexia nervosa and years of education, which positions anor-
exia nervosa as unique among the psychiatric disorders we
investigate. These findings encourage a deeper investigation of
metabolic pathways that may be implicated in psychiatric dis-
orders to identify potential targets for preventive strategies.
Results
Genetic overlap between the sexes. Body composition and
physical activity showed substantial heritability explained by
common genetic variation ranging from 28–51% (standard error
(s.e.)= 0.4–0.8%, LDSC; Supplementary Table 3) and sex-
dependent sets of genomic variation at pBonferroni= 0.05/28=
0.002. We detected a genetic correlation between males and
females in BF% that was significantly different from 1 (rg= 0.89,
s.e.= 0.03; p≠1= 4.7 × 10−4, LDSC). Sensitivity analyses using
Haseman–Elston regression38 confirmed these results (Supple-
mentary Table 3) and suggest that specific sets of genomic var-
iation associated with BF% may be differentially active in females
and males. The genetic correlations between females and males
for the remaining traits are presented in Supplementary Table 4.
Detailed results for the body composition and physical activity
GWASs, including significant hits and Manhattan plots, are
presented on Functional Mapping and Annotation (FUMA;
URLs) entry 20–22 and 38–41.
Genetic overlap of psychiatric and body composition traits. In
the genetic correlations of the psychiatric disorders and beha-
vioural traits with body composition and physical activity, distinct
patterns emerged resulting in two groups (Table 1). In the first
group, anorexia nervosa, education years, OCD and schizophrenia
were significantly negatively associated with BF%, while anorexia
nervosa and schizophrenia were also significantly negatively asso-
ciated with FFM (see Fig. 1 and Supplementary Data 2 for full
results). By contrast, in the second group, ADHD, heavy smoking,
alcohol dependence and insomnia were significantly positively
associated with BF%, while only ADHD and heavy smoking were
also significantly positively associated with FFM (Table 1). The
p value threshold for the genetic correlations with body composi-
tion traits was pBonferroni= 0.05/190= 2.6 × 10−4 using matrix
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decomposition of the genetic correlation matrix to identify the
number of independent tests to adjust the threshold using Bon-
ferroni correction39.
Sex differences in genetic correlations. The genetic correlation
of anorexia nervosa with BF% in females (rg=−0.44, s.e.= 0.04,
LDSC) was stronger than with BF% in males (rg=−0.26,
s.e.= 0.04, LDSC) with a significant difference of δrg=−0.17
(p= 4.2 × 10−5, LDSC jackknife). Conversely, education years
showed a stronger genetic correlation with FM in males than in
females (δrg= 0.10, p= 1.3 × 10−4, LDSC jackknife), which was
also seen with FFM (δrg= 0.09, p= 1.7 × 10−4, LDSC jackknife).
No other sex differences were observed (Supplementary Data 3).
Putative causal relationships. GSMR revealed evidence con-
sistent with putative causal relationships between psychiatric
traits and body composition. The effects on continuous traits are
expressed as β coefficients (Fig. 2a–c, e, Supplementary Fig. 1),
whereas the effects on binary traits are presented as odds ratios
(ORs; Fig. 2d). Estimates with binary exposures were converted to
the liability scale40. The Bonferroni-corrected p value was 0.05/
190= 2.6 × 10−4 for the GSMR analyses (Supplementary Data 4,
5). In the first group, GSMR showed evidence for a 1.8 kg
decrease in FM per standard deviation of liability to anorexia
nervosa (p= 2.3 × 10−8, GSMR) that was more pronounced in
females (βAN→FM=−2.14, p= 1.9 × 10−5, GSMR) than in males
(βAN→FM=−1.3, p= 4.9 × 10−4, GSMR). This mirrored the
observed genetic correlations. Additionally, GSMR showed evi-
dence for a 3.7 kg decrease in FM per year of education (p= 5.1 ×
10−38, GSMR). Furthermore, GSMR showed a 0.88 kg decrease in
FM (p= 3.3 × 10−13, GSMR) and a 0.58 kg decrease in FFM (p=
4.5 × 10−13, GSMR) per standard deviation of liability to schi-
zophrenia (Supplementary Data 4). GSMR results for the second
group showed no evidence for an influence of ADHD on fat mass
(p= 0.23, GSMR). However, GSMR showed evidence in the
reverse direction with a 1.05-fold increase in risk for ADHD per
kg FM (p= 1.3 × 10−12, GSMR) as well as a 1.03-fold increase
in risk for ADHD per kg FFM (p= 2.0 × 10−5, GSMR) and a
1.04-fold increase in heavy smoking per kg FM (p= 6.7 × 10−8,
GSMR; Supplementary Data 5).
Genetic correlations with physical activity. In the first group,
OCD (rg= 0.28, s.e.= 0.07, LDSC) and anorexia nervosa (rg=
0.17, s.e.= 0.05, LDSC) correlated positively with objectively
measured physical activity, whereas education years showed a
significant correlation with physical activity only in females (rg=
0.17, s.e.= 0.04, LDSC; Supplementary Data 2). However, when
formally tested the genetic correlation was not significantly dif-
ferent from the correlation observed in males (Supplementary
Data 3). Neither ADHD (p= 0.20, LDSC) nor any other trait in
the second group correlated with physical activity (Supplemen-
tary Data 2).
Genetic correlations with glycaemic traits. Our investigation
into whether the relationships of the psychiatric traits with body
composition are mirrored in their relationships with glycaemic
traits (Fig. 3) showed that anorexia nervosa (rg=−0.28; p= 1.8 ×
10−7, LDSC) and education years (rg=−0.28, p= 1.0 × 10−12,
LDSC) correlated genetically negatively with fasting insulin con-
centrations. Accordingly, anorexia nervosa (rg=−0.29, p= 2.8 ×
10−5, LDSC) and education years (rg=−0.33, p= 9.2 × 10−6,
LDSC) also showed negative genetic correlations with insulin
resistance. In addition, education years showed a negative genetic
correlation with fasting glucose concentrations (rg=−0.14; p=
2.1 × 10−5, LDSC), whereas heavy smoking showed a positive
genetic correlation with fasting glucose concentrations (rg= 0.22;
p= 2.0 × 10−4, LDSC; Supplementary Data 6). No other psychia-
tric traits showed a genetic correlation with glycaemic traits passing
our significance threshold.
Sensitivity analyses with female-only and male-only GWASs of
the psychiatric and behavioural traits resulted in similar results,
indicating that the patterns and results are consistent and largely
independent of female-to-male ratios in the sex-combined GWAS
(Supplementary Data 2, 6 and Supplementary Figs. 2a–3b).
Sensitivity analyses not adjusting the body composition GWASs
for alcohol consumption or smoking yielded the same results
(Supplementary Data 7).
Table 1 Significant genetic correlations between psychiatric disorders, behavioural traits and body composition traits.
Psychiatric/behavioural trait Body composition rg s.e. p
Group 1
Anorexia nervosa Body fat % −0.34 0.03 2.09 × 10−27
Anorexia nervosa Fat-free mass −0.14 0.03 5.79 × 10−06
Education years Body fat % −0.34 0.02 7.11 × 10−60
Education years Fat-free mass −0.03 0.02 0.14 (n.s.)
OCD Body fat % −0.31 0.05 9.82 × 10−10
OCD Fat-free mass −0.12 0.04 0.01 (n.s.)
Schizophrenia Body fat % −0.09 0.02 7.30 × 10−06
Schizophrenia Fat-free mass −0.08 0.02 2.00 × 10−04
Group 2
ADHD Body fat % 0.30 0.03 2.50 × 10−21
ADHD Fat-free mass 0.17 0.03 3.84 × 10−11
Smoking Body fat % 0.29 0.03 3.59 × 10−23
Smoking Fat-free mass 0.15 0.03 9.94 × 10−08
Alcohol dependence Body fat % 0.23 0.06 2.00 × 10−04
Alcohol dependence Fat-free mass 0.04 0.05 0.45 (n.s.)
Insomnia Body fat % 0.23 0.04 2.27 × 10−08
Insomnia Fat-free mass 0.06 0.03 0.11 (n.s.)
Note: The correlations were calculated using LDSC11. The table presents the significant findings. The full results can be found in Supplementary Data 2. Bonferroni-corrected p value threshold: ɑ= 0.05/
190= 0.0002
LDSC linkage disequilibrium score regression, rg genetic correlation, s.e. standard error, p p value, n.s. not significant after correction for multiple testing, ADHD attention-deficit/hyperactivity disorder,
OCD obsessive compulsive disorder
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Fig. 1 Sex-specific genetic correlations across body composition, physical activity and psychiatric traits. Sex-specific genetic correlations of body
composition traits (n= up to 155,961) and physical activity (n= up to 66,224) with sex-combined psychiatric disorders (n= up to 77,096) and behavioural
traits (n= up to 157,355). The autosomal genetic correlations were calculated by bivariate linkage disequilibrium score regression (LDSC). Coloured bars
represent genetic correlations, error bars depict standard errors (s.e.) and asterisks indicate statistically significant genetic correlations with p values less
than α= 0.0003. This threshold was calculated via the identification of the number of independent tests using matrix decomposition of the genetic
correlation matrix and subsequent Bonferroni correction of α= 0.05 for 190 independent tests. ADHD= attention-deficit/hyperactivity disorder, BF%=
body fat percentage, FFM= fat-free mass, FM= fat mass, PA= physical activity.
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Fig. 2 Causal associations between body composition and psychiatric traits. Results are shown from generalized summary data-based Mendelian
randomization (GSMR) analyses. Colours represent the sex of the body composition trait: red for female effects, blue for male effects and yellow for
sex-combined effects. Error bars represent 95% confidence intervals (95% CIs) and asterisks indicate statistically significant estimates with p
values less than α= 2.6 × 10−4. a Putative causal associations of exposures (rows) psychiatric disorders (n= up to 77,096) and behavioural traits
(n= up to 217,568) with outcomes (columns) body composition traits (n= up to 155,961). Dots represent the effect sizes (as measured by β, bxy)
on the liability scale of the disorders or traits. b, c Mendelian randomization results for the exposures anorexia nervosa and education years on
the outcomes the body composition traits. These are plotted differently due to the size of the effects. All estimates are presented together in
Supplementary Fig. 1 on the same scale. d Putative causal associations of exposures (rows) body composition traits (n= up to 155,961) with outcomes
(columns) psychiatric disorders (n= up to 77,096) and behavioural traits (n= up to 217,568). Dots represent the effect sizes (as measured by odds
ratios, ORs) of risk factors on disorders or traits. e The Mendelian randomization results for body composition traits as exposures on the outcome
years of education. Dots represent the effect sizes (as measured by β, bxy) on the scale of the risk factors. Abbreviations: ADHD= attention-deficit/
hyperactivity disorder, AN= anorexia nervosa, BF%= body fat percentage, EduYears= education years, FFM= fat-free mass, FM= fat mass, OCD=
obsessive compulsive disorder, SCZ= schizophrenia.
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Fig. 3 Sex-specific genetic correlations across glycaemic traits and psychiatric traits. Sex-specific genetic correlations of glycaemic traits (n= up to
140,583) with sex-combined psychiatric disorders (n= up to 77,096) and behavioural traits (n= up to 157,355). The autosomal genetic correlations
were calculated by bivariate linkage disequilibrium score regression (LDSC). Coloured bars represent genetic correlations, error bars depict standard
errors (s.e.) and asterisks indicate statistically significant genetic correlations with p values less than α= 0.0002. This threshold was calculated
via the identification of the number of independent tests using matrix decomposition of the genetic correlation matrix and subsequent Bonferroni
correction of α= 0.05 for 231 independent tests. ADHD= attention-deficit/hyperactivity disorder, Glu= fasting glucose, Ins= fasting insulin, IR=
insulin resistance, adj= adjusted.
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Age-dependent genetic correlations. As a secondary aim, we
explored the developmental dependence of genetic correlations of
BMI and FFM at different ages with psychiatric disorders and
behavioural traits (Fig. 4). We used BMI as a proxy measure of
BF% as no GWAS of BF% in childhood or adolescence were
available. To test if the sets of genetic variants affecting body
composition at different stages of life differentially correlate with
psychiatric disorders and behavioural traits, we estimated the
following genetic BMI correlations and tested if they were sig-
nificantly different from one41: between childhood and adoles-
cence/young adulthood (rg= 1.00, s.e.= 0.07, LDSC), between
childhood and later adulthood (rg= 0.66, s.e.= 0.04, LDSC) and
between adolescence and later adulthood (rg= 0.80, s.e.= 0.05,
LDSC). The genetic correlation of FFM between childhood and
adulthood was also significantly different from one (rg= 0.30,
s.e.= 0.04, LDSC). As above, multiple psychiatric disorders and
traits showed significant positive and negative genetic correlations
with adult BMI and FFM. However, neither BMI in childhood,
adolescence or young adulthood, nor FFM in childhood,
showed significant genetic correlations with any of the psychiatric
disorders or behavioural traits (Supplementary Data 8). To
additionally test an extreme phenotype, we calculated genetic
correlations between psychiatric traits and obesity in childhood.
Within the first group, only education years (rg=−0.19, s.e.=
0.03, LDSC) correlated negatively with obesity in childhood.
In the second group, ADHD was the only psychiatric disorder
that showed a significant positive genetic correlation with obesity
in childhood (rg= 0.22, s.e.= 0.05, LDSC). GSMR analyses gave
evidence for a 1.42-fold increase for ADHD per kg/m2 increase in
childhood BMI (p= 1.26 × 10−8, GSMR).
Discussion
Symptomatically, psychiatric disorders are often accompanied by
alterations in energy intake, energy expenditure and body com-
position. Recent genetic analyses of BMI found an important role
for genes expressed in the brain and specific brain cell types22,
suggesting that BMI may be a metabo-behavioural trait. This
spurred our in-depth investigation of the shared genetics of
psychiatric traits and body composition. We were able to show
that five psychiatric disorders—anorexia nervosa, OCD, schizo-
phrenia, ADHD and alcohol dependence—as well as three
behavioural traits—education years, insomnia and heavy smoking
—show significant genetic correlations (i.e. shared genetics) with
body composition in two distinct patterns.
The first group of psychiatric disorders and behavioural traits
included anorexia nervosa, OCD, schizophrenia and education
years, and was characterized by genetic correlations with genomic
variants predisposing to lower BF% and FFM. The second group
comprised ADHD, alcohol dependence, heavy smoking and
insomnia, and had genetic correlations with genomic variants
predisposing to higher BF% and FFM. Our Mendelian rando-
mization analyses used significant genetic variants as instru-
mental variables and found that anorexia nervosa, schizophrenia
and education years showed evidence consistent with a negative
causal effect on FM and, in the reverse direction, higher BF%
appeared to be a risk factor for both ADHD and heavy smoking.
Our results also suggested that the overweight seen in individuals
with schizophrenia in epidemiological studies42 is likely to
represent medication effects43 given our observations of a puta-
tive causal effect of schizophrenia on lower FM and FFM. This
finding reiterates the pressing need for the development of new
antipsychotic medications with more favourable weight-related
side effect profiles.
In our analysis, anorexia nervosa showed a stronger correlation
with BF% in females than in males. This phenomenon was not
observed for other traits genetically associated with anorexia
nervosa, such as neuroticism, anxiety, major depressive disorder,
OCD or schizophrenia41. These findings suggest that anorexia
nervosa and BF% may share a sex-dependent set of genomic
variants potentially contributing to the marked sex bias in the
prevalence of anorexia nervosa. Education years showed a
stronger genetic correlation with FM in males than in females.
However, the GSMR analysis showed a more pronounced pro-
tective effect of education years on FM in females than in males in
line with a large epidemiological study44. This suggests that the
stronger genetic association between education years and FM in
males may be driven by a set of pleiotropic variants.
From a developmental perspective, it is striking that GWASs of
body composition across ages do not genetically correlate per-
fectly with each other. These varying genetic effects across the
lifespan41,45 have been termed “genetic innovation”46 and
represent the effects of partially different, age-dependent sets of
genomic variants on body composition regulation at certain
periods of life41,45. Some of the psychiatric disorders, such as
ADHD and anorexia nervosa, typically have their onset in
childhood or adolescence with preceding symptoms or beha-
viours that implicate neurodevelopmental components. We used
the available life-stage GWASs of body composition and did not
find genetic overlap between childhood or adolescence/young
adulthood BMI with psychiatric disorders, but instead found
significant genetic correlations of psychiatric disorders with later
adult BMI and BF%. Our analyses also show that genetic variants
associated with obesity before the age of ten were positively
correlated only with ADHD and negatively only with education
years. The relatively specific positive genetic correlation of
childhood obesity with ADHD recapitulates a large body of
clinical evidence of high phenotypic comorbidity47, also shown in
family studies48. Overweight may represent a difficult but
potentially intervenable risk factor at a young age.
Our finding of a genetic overlap between ADHD and obesity in
childhood may implicate shared biological pathways between
both traits. Given our other results, it appears that this shared
component is unlikely to be related to physical activity or gly-
caemic traits. Instead, speculatively, a central nervous system
pathway that is dysregulated by increased body mass in childhood
may increase the liability to develop ADHD.
We also investigated body composition-related traits, including
physical activity, fasting insulin and fasting glucose concentra-
tions. Physical activity showed a positive genetic correlation with
anorexia nervosa and OCD, which themselves were negatively
genetically correlated with BF%. Carrying genetic variants that
predispose to higher physical activity may be associated with the
relationship between lower BF% and psychiatric traits. Higher
physical activity, therefore, should be carefully assessed in the
treatment of patients with compulsive psychiatric disorders like
anorexia nervosa and OCD as it may be a genetically mediated
behaviour, as indicated by our analysis.
Contrary to our expectations, ADHD did not show a genetic
correlation with physical activity. This suggests that hyperactivity
in ADHD may not originate from biological liability for higher
accelerometer-measured physical activity49 and is likely to have
an alternative cause, such as insufficient inhibitory control as
observed in paediatric clinical samples with ADHD50, healthy
adult population samples51, and in a large longitudinal develop-
mental cohort study52.
Our analyses showed that anorexia nervosa and education
years have a negative genetic correlation with fasting insulin
concentrations and insulin resistance, positioning anorexia ner-
vosa as a special case within the psychiatric disorders and
potentially differentiating it from OCD. These negative correla-
tions with fasting insulin concentrations mirrored the negative
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Fig. 4 Age-dependence of sex-specific genetic correlations across body composition and psychiatric traits. Sex-specific genetic correlations of body
mass index (BMI) and fat-free mass (n= up to 157,355) with psychiatric disorders (n= up to 77,096) and behavioural traits (n= up to 157,355) across the
lifespan. Participants of the childhood BMI GWAS (green, n= 35,668) were younger than 10 years, the participants of the young adulthood GWASs
(lighter colours, n= 29,054) were between 15 and 35 years, participants of the late adulthood GWAS (darker colours, n= 155,961) were between 39–75
years old. Overweight in childhood (lime green; n= 13,848) was included as an extreme phenotype. The autosomal genetic correlations were calculated by
bivariate linkage disequilibrium score regression (LDSC). Coloured bars represent genetic correlations, error bars depict standard errors (s.e.) and asterisks
indicate statistically significant genetic correlations with p values less than α= 0.0002. This threshold was calculated via the identification of the number
of independent tests using matrix decomposition of the genetic correlation matrix and subsequent Bonferroni correction of α= 0.05 for 210 independent
tests. ADHD= attention-deficit/hyperactivity disorder.
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genetic correlations between anorexia nervosa, education years
and BF%. The potential involvement of metabolic hormones like
insulin in anorexia nervosa underscores the relationship of brain
and body and their reciprocal regulation53, opening an avenue for
deeper investigation of metabolic components in psychiatric
disorders. The genetic correlations of ADHD with glycaemic
traits were not significant, implying that these traits play a smaller
role in ADHD than in anorexia nervosa, given the comparable
sample size of the GWASs on both psychiatric disorders25,26.
Genetic associations of physical activity and glycaemic traits with
body composition and psychiatric traits in plausible directions
render them interesting candidates for formal mediation analyses
as they may be actionable targets54.
Our study represents the largest investigation of sex- and age-
dependent effects in the genomic overlap of body composition
and psychiatric traits. Although our analyses drew on the largest
available GWASs, some phenotypes still had relatively small
sample sizes for genomic investigations of common variants in
complex traits, especially for our sex-specific analyses. These
should be repeated when sample sizes have increased, especially
for OCD as its currently available GWAS sample size is parti-
cularly modest. All Mendelian randomization analyses, using
GSMR37, with body composition or glycaemic traits, ADHD,
education years, schizophrenia or heavy smoking as exposure
were sufficiently powered; however, the analyses with anorexia
nervosa, insomnia or OCD as exposures should be regarded as
exploratory in nature because p value thresholds were lowered to
include at least 10 single-nucleotide polymorphisms (SNPs) in the
instrument variable.
Finally, the age-dependent genetic influences we observed
between psychiatric traits and body composition suggests that
future research could focus on a developmental approach to
GWAS analyses of body composition, to capture age- and sex-
dependent differences. These differences have already been sug-
gested by larger twin studies55,56 and two molecular genetic
studies41,45, which enabled our examination of their relationship
with psychiatric traits. Most importantly, shared biological
pathways and common environmental factors influencing both
body composition and behavioural traits should be studied as
potential targets for interventions.
Methods
UK Biobank subsample. We performed GWASs on an unrelated (KING relat-
edness metric >0.044, equivalent to a relatedness value of 0.088; nrelated= 7765)
European subsample (defined by 4-means clustering of the genetic principal
components)57 of the genotyped UK Biobank participants (n= 155,961, 45%
female, 32% of the genotyped participants, Supplementary Table 1)58,59. The UK
Biobank (URLs) is a prospective cohort sampled from the general population
between 2006 and 2010. All participants were between 40 and 69 years old, were
registered with a general practitioner through the United Kingdom’s National
Health Service, and lived within travelling distance of one of the assessment
centres.
Ethics. The UK Biobank is approved by the North West Multi-centre Research
Ethics Committee. All procedures performed in studies involving human partici-
pants were in accordance with the ethical standards of the North West Multi-centre
Research Ethics Committee and with the 1964 Declaration of Helsinki and its later
amendments or comparable ethical standards. All participants provided written
informed consent to participate in the study. This study has been completed under
UK Biobank approved study application 27546.
Power calculations of the GWASs. We conducted power calculations for the
female and male GWASs using the Genetic Power Calculator60. A minimum of
39,580 individuals is required to detect a SNP that accounts for 0.1% of trait
variance at 80% power at a genome-wide significance threshold of p ≤ 5 × 10−8 and
a minor allele frequency of 0.20. According to these results, the female and the male
GWASs were sufficiently powered to detect genome-wide significant loci with
70,700 females and 85,261 males. With these parameters, the female GWAS had a
power of 99.8% and the male GWAS of 99.9%.
GWASs on body composition traits in the UK Biobank. The continuous body
composition traits—BF%, FM, FFM and BMI—were measured using the validated
bioelectrical impedance analyser Tanita BC-418 MA (Tanita Corporation,
Arlington Height, IL) at every assessment centre61,62 for every participant across
the UK. We applied trait-specific medication and illness filtering to exclude par-
ticipants with compromised hydration status and medications or illnesses known
to affect body composition to identify genetic variation associated with body
composition phenotypes that is not confounded by illnesses and their downstream
effects or metabolism-changing medication. We applied stringent exclusion criteria
and covaried for addictive behaviour-related phenotypes, including smoking and
alcohol consumption (for exclusion criteria, see Supplementary Table 2). We
regressed the body composition traits on factors related to assessment centre,
genotyping batch, smoking status, alcohol consumption, menopause and con-
tinuous measures of age, and socioeconomic status (SES) measured by the
Townsend Deprivation Index63 as independent variables. We took the residuals
from these regressions as our phenotypes for the GWASs. We included 7,794,483
SNPs and insertion–deletion variants (hereafter referred to as SNPs) with a minor
allele frequency >1%, imputation quality scores >0.8, and that were genotyped, or
present in the HRC reference panel64 and used an additive model on the imputed
dosage data provided by UK Biobank, using BGENIE v1.265. We accounted for
underlying population stratification by including the first six principal components,
calculated on the genotypes of our European subsample using FlashPCA266. We
performed GWASs including incremental numbers of principal components and
checked each GWAS for inflation by calculating its LDSC intercept. We identified
six principal components as the optimal number to adjust for population stratifi-
cation within the European subsample and to not overcorrect the analysis retaining
the greatest signal. Additionally, we included assessment centre as a covariate to
adjust for population stratification. We then meta-analysed the sex-specific GWASs
using METAL67 (URLs) applying an inverse variance-weighted model with a fixed
effect, to obtain sex-combined results.
Clumping and genome-wide significant loci. Significantly associated SNPs (p <
5 × 10−8) were considered as potential index SNPs. SNPs in LD (r2 > 0.2) with a
more strongly associated SNP within 3000 kb were assigned to the same locus using
FUMA (URLs)68. Overlapping clumps were merged with a second clumping
procedure in FUMA, merging all lead SNPs with r2= 0.1 to genomic loci. After
clumping, independent genome-wide significant loci (5 × 10−8) were compared
with entries in the NHGRI-EBI GWAS catalogue69, using FUMA68.
Heritability estimation and investigation of sex differences. To ensure the
robustness of our results, we applied multiple approaches to calculate heritability
estimates and genetic correlations. We used BOLT-LMM70, LDSC11 and GREML71
implemented in GCTA72 to calculate common variant h2SNP (URLs). Additionally,
we calculated the genetic correlation between females and males using LDSC11 and
Haseman–Elston regression38 implemented in GCTA72 to estimate sex differences
in the genetic architecture of the body composition, glycaemic traits and physical
activity. Haseman–Elston regression uses the cross-product of phenotypes for
pairwise individuals and a genetic relatedness matrix to calculate heritability and
genetic correlations73. All other statistics were calculated in R 3.4.1 if not otherwise
stated (URLs).
GWASs of psychiatric disorders and behavioural traits. All of the following
traits were used for the sex-specific and age-dependent analyses (Supplementary
Data 1). The sex-specific summary statistics for the psychiatric disorders, including
major depressive disorder27, schizophrenia3, anorexia nervosa25, bipolar
disorder74,75, ADHD26,76, alcohol dependence77, autism spectrum disorder78 and
PTSD79, were provided by the PGC (URLs), for OCD80,81 by International
Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC)
and OCD Collaborative Genetics Association Studies (OCGAS), for borderline
personality disorder82 by the German Borderline Genomics Consortium, for
cannabis use by the International Cannabis Consortium83, for anxiety84 by our
own group, for insomnia85 by the Complex Trait Genetics group at VU University
Amsterdam (URLs), for heavy smoking86 by University of Leicester available from
the UK Biobank (URLs), for the behavioural traits years of education87 by the
Social Science Genetic Association Consortium (SSGAC) (URLs), for neuroticism41
by our own group (Supplementary Data 1) and for migraine88,89 by International
Headache Genetics Consortium (IHGC). Glycaemic traits’90 summary statistics
were provided by the Meta-Analyses of Glucose and Insulin-related traits Con-
sortium (MAGIC), whereas childhood obesity91 results were provided by the Early
Growth Genetics (EGG, URLs) Consortium, BMI in young adulthood by Graff
et al.92 and physical activity by our group41.
Genetic correlations. Using an analytic extension of LDSC11, we calculated SNP-
based bivariate genetic correlations (rg) to examine the genetic overlap of body
composition and glycaemic traits with psychiatric and behavioural traits and dis-
orders in a sex-specific manner. Differences in genetic correlations were calculated
and their s.e.’s were calculated using a block jackknife approach as previously
described41.
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Generalized summary data-based Mendelian randomization. We investigated
putative causal bidirectional relationships between these traits using GSMR37.
Mendelian randomization is a method that uses genetic variants as instrumental
variables, which are expected to be independent of confounding factors, to test for
causative associations between an exposure and an outcome93. Mendelian rando-
mization can be used to infer credible causal associations when randomized-
controlled trials are not feasible or are unethical93. GSMR performs a multi-SNP
Mendelian randomization analysis using summary statistics. Let z be a genetic
variant (e.g. SNP), x be the exposure (e.g. psychiatric disorder) and y be the
outcome (e.g. body composition trait). First, GSMR is based on the premise that
several nearly independent SNPs (z) are associated with the exposure (x). Second, it
assumes that the exposure (x) has an causal effect on y. If both assumptions hold
true, the SNPs that are associated with the exposure (x) will exert an effect on the
outcome (y) via the exposure (x). If in this instance no pleiotropy is present, the
estimate (bxy) at any of the SNPs that are associated with the exposure (x) should
be highly similar, because each effect of all SNPs on the outcome (y) will be
mediated through the exposure (x). With the help of a generalized least squares
(GLS) model, the estimates of bxy of each SNP that is associated with the exposure
(x) can be combined, resulting in higher statistical power37,94. The GSMR method
essentially implements summary data-based Mendelian randomization analysis for
each SNP instrument individually, and integrates the bxy estimates of all the SNP
instruments by GLS, accounting for the sampling variance in both bzx and byz for
each SNP and the LD among SNPs. We used individual-level genotype data from a
subsample of the anorexia nervosa GWAS to approximate the underlying LD
structure to account for LD between the variants in the multi-SNP instrument.
Pleiotropy is an important potential confounding factor that could bias the esti-
mate and often results in an inflated test statistic in Mendelian randomization
analysis. We also removed potentially pleiotropic SNPs (i.e. SNPs that have effects
on both risk factor and outcome) from this analysis using the heterogeneity in
dependent instruments outlier method37,95 that detects pleiotropic SNPs at which
the estimates of bxy are significantly different from expected under a causal model.
The power of detecting a pleiotropic SNP depends on the sample sizes of the
GWAS data sets and the deviation of bxy estimated at the pleiotropic SNP from the
causal model. Based on this, the overall bxy can be estimated from all the instru-
ments remaining using a GLS approach that takes the LD between the variants and
the correlations between their effect sizes into account by modelling them in a
covariance matrix. Additionally, GSMR uses the intercept of the bivariate LD score
regression to account for potential sample overlap between the GWASs used as
instruments for the exposure or outcome12. Estimates with binary exposures were
converted to the liability scale40. Some of these analyses are exploratory because a
few utilised GWASs were underpowered (i.e. did not detect ≥10 genome-wide
significant independent loci at a p value level of 5 × 10−8) and we therefore lowered
the p value threshold for inclusion, in order to include at least 10 independent SNP
instruments as previously recommended37.
Correction for multiple testing. We calculated the number of independent traits
by matrix decomposition (i.e. number of principal components accounting for
99.5% of variance explained) and adjusted our p value threshold accordingly. The
first matrix of the main analysis contained all 17 psychiatric traits, all four body
composition traits, physical activity and childhood obesity (Supplementary Data 2).
All sex-specific correlations were entered when available. The second matrix
comprised all 17 psychiatric traits and all glycaemic traits listed in Supplementary
Data 6, including their sex-specific correlations. The family-wise Bonferroni-cor-
rected p value threshold for the main analysis, including the genetic correlations
with body composition traits and physical activity, was pBonferroni= 0.05/190=
2.6 × 10−4 and the family-wise p value threshold for the genetic correlations with
glycaemic traits was pBonferroni= 0.05/231= 2.2 × 10−4.
URLs. For METAL, see http://csg.sph.umich.edu/abecasis/metal/; for FUMA, see
http://fuma.ctglab.nl/; for SSGAC, see https://www.thessgac.org/; for Complex
Traits Genetics lab, see https://ctg.cncr.nl; for International Headache Genetics
Consortium, see http://www.headachegenetics.org/; for the MAGIC, see https://
www.magicinvestigators.org/; for UK Biobank, see https://www.ukbiobank.ac.uk/;
for the PTSD working group of the Psychiatric Genomics Consortium, see https://
pgc-ptsd.com/; for the Psychiatric Genomics Consortium, see http://www.med.unc.
edu/pgc; for the R project, see https://www.r-project.org/; for the EGG Consortium,
see https://egg-consortium.org/.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Supplementary Data 1 contains all information on data availability, including download
links for summary statistics. Summary statistics for the body composition GWASs are
available at www.topherhuebel.com/GWAS and the GWAS catalogue (www.ebi.ac.uk/
gwas/). All sex-combined summary statistics for the psychiatric disorders are available at
www.med.unc.edu/pgc/results-and-downloads/ and for glycaemic traits at https://www.
magicinvestigators.org/. Sex-specific summary statistics of the psychiatric disorders can
be requested from each working group of the Psychiatric Genomics Consortium by
submitting a secondary analysis proposal. The data that support the findings of this study
are available from UK Biobank (www.ukbiobank.ac.uk). Restrictions apply to the
availability of these data, which were used under license for the current study (Project ID:
27546). Data are available for bona fide researchers upon application to the UK Biobank.
Code availability
Analysis code can be accessed on github.com/topherhuebel/ukbgwas. Software can be
accessed for BGENIE, at https://jmarchini.org/bgenie/; for BOLT-LMM v2.3.2, at https://
data.broadinstitute.org/alkesgroup/BOLT-LMM/; for LDSC, at v1 https://github.com/
bulik/ldsc; for METAL, at http://csg.sph.umich.edu/abecasis/metal/; for, at R 3.4 https://
www.r-project.org/; for GSMR, at https://cnsgenomics.com/software/gcta/
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